Answers are grounded in this paper and cite their sources.
A letter to the editor defending the clinical utility of digoxin for atrial fibrillation against claims that its use is based on mythology.
Letters1 June 1991Requiem for Digoxin?Jacob Zatuchni, MDJacob Zatuchni, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-114-11-993_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editors:Falk and Leavitt (1) would like to sound the death knell for digoxin as therapy for atrial fibrillation. They cannot understand why the drug has been popular for 200 years and conclude that it must be because of mythology and not science. Although aware of the beneficial effects of digoxin in patients with atrial fibrillation, they choose to emphasize its questionable use for prevention of atrial fibrillation in patients who have reverted to sinus rhythm, the possibility that digoxin makes recurrences of atrial fibrillation worse, and the questionable significance of tachycardia during exercise if it occurs. They...References1. FalkLeavitt RJ. Digoxin for atrial fibrillation: a drug whose time has gone? Ann Intern Med. 1991;114:573-5. LinkGoogle Scholar2. PritchettMcCarthyWilkinson EEW. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. Ann Intern Med. 1991;114:539-44. LinkGoogle Scholar3. PietersenHellemann AH. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Am J Cardiol. 1991;67:713-7. CrossrefMedlineGoogle Scholar4. CoplenAntmanBerlinHewittChalmers SEJPT. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. Circulation. 1990;82:1106-16. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Jacob Zatuchni, MDAffiliations: Pennsylvania Hospital Philadelphia, PA 19139 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDigoxin: Mythology or Evidence?Rodney H. Falk, MD 1 June 1991Volume 114, Issue 11Page: 993-993KeywordsAtrial fibrillationDrugsExerciseTachycardia ePublished: 1 December 2008 Issue Published: 1 June 1991 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Jacob Zatuchni (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: